Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
agreement, allocate, argument, arising, aseptic, attributable, awaiting, born, broader, cannibalization, classified, collaboration, commensurate, component, cut, deprived, EMA, erhvervsdrivende, erode, exceed, FirmTo, fonde, formation, fraction, fractionation, Fruergaard, GOI, Harno, hereto, Hewitt, Innate, inspection, installation, Interaction, invalid, Iran, Iranian, Jakob, letter, Liz, lov, mandatory, misappropriating, network, NNE, OAD, om, PCAOB, Pharma, Pharmaplan, plasma, pre, procurement, progressing, regular, regularly, rely, renewed, Ryzodeg, Scheibye, small, Spanish, spun, Squibb, Sten, Tehran, Tresiba, unable, undergo, unenforceable, upcoming, vention, Warning, wholly
Removed:
birth, buy, exercised, originally, primary, recently, restated, SFDA, spinning, substance, unit, Wedel
Filing tables
Filing exhibits
NVO similar filings
Filing view
External links
Exhibit 15.3
Consent of independent registered public accounting firm |
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-82318 and No. 333-83724) of Novo Nordisk A/S of our report dated January 30, 2013 relating to the Consolidated Financial Statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.
/s/ PricewaterhouseCoopers
Statsautoriseret Revisionspartnerselskab
Copenhagen, Denmark
February 6, 2013